Prices delayed by at least 15 minutes | Prices updated on 02 May 2025, 18.01 BST | Print


Astrazeneca PLC (AZN)

ORD SHS $0.25
Sell: 10,756.00p|Buy: 10,760.00p|Change: 146.00 (1.38%)

Open 

10,656.00p


Previous close 

10,608.00p


Trade high 

10,792.00p


Volume 

2,168,988


Year high 

13,388.00p


Year low 

9,573.51p


Dividend yield 

2.29%


Market capitalisation 

£166.71 bn


P/E ratio 

28.44


ISIN 

GB0009895292


Share price

Dividends

PreviousLatest
Record date09/08/202421/02/2025
Ex-dividend date08/08/202420/02/2025
Payment date09/09/202424/03/2025
Amount77.60p168.00p

Performance 02/05/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Astrazeneca PLC+ 1.38
FTSE 100+ 1.17
More...

Company profile

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

Sector 

Healthcare


Recent trades

DateTimePriceQuantityValue (£)
02/05/202504:55:0010754131,398.02
02/05/202504:26:391074400.00
02/05/202504:26:391074400.00
02/05/202504:26:391074400.00
02/05/202504:28:251074600.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.